"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Descriptor ID |
D009369
|
MeSH Number(s) |
C04
|
Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 17 | 3 | 20 |
1996 | 14 | 6 | 20 |
1997 | 15 | 9 | 24 |
1998 | 14 | 3 | 17 |
1999 | 12 | 2 | 14 |
2000 | 17 | 5 | 22 |
2001 | 21 | 5 | 26 |
2002 | 26 | 9 | 35 |
2003 | 35 | 11 | 46 |
2004 | 47 | 14 | 61 |
2005 | 34 | 12 | 46 |
2006 | 35 | 11 | 46 |
2007 | 52 | 14 | 66 |
2008 | 49 | 13 | 62 |
2009 | 45 | 11 | 56 |
2010 | 50 | 7 | 57 |
2011 | 59 | 14 | 73 |
2012 | 69 | 10 | 79 |
2013 | 65 | 15 | 80 |
2014 | 91 | 16 | 107 |
2015 | 112 | 10 | 122 |
2016 | 79 | 22 | 101 |
2017 | 93 | 12 | 105 |
2018 | 91 | 9 | 100 |
2019 | 111 | 17 | 128 |
2020 | 136 | 12 | 148 |
2021 | 129 | 7 | 136 |
2022 | 119 | 1 | 120 |
2023 | 110 | 3 | 113 |
2024 | 63 | 30 | 93 |
2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Childhood Cancer-Connect: Identifying solutions to elevating the cancer experience for adolescents and young adults with cancer. J Natl Cancer Inst. 2025 Feb 01; 117(2):229-239.
-
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Nat Commun. 2025 Jan 02; 16(1):32.
-
Targeting molecular pathways to control immune checkpoint inhibitor toxicities. Trends Immunol. 2025 Jan; 46(1):61-73.
-
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation. Cochrane Database Syst Rev. 2024 12 19; 12:CD014966.
-
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference. Oncoimmunology. 2025 Dec; 14(1):2432726.
-
Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity. Proc Natl Acad Sci U S A. 2024 Dec 17; 121(51):e2407910121.
-
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature. 2025 Jan; 637(8048):1218-1227.
-
Genetic and environmental risks for clonal hematopoiesis and cancer. J Exp Med. 2025 Jan 06; 222(1).
-
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview. Biochim Biophys Acta Rev Cancer. 2025 Feb; 1880(1):189233.
-
Exploring the potential of TGFß as a diagnostic marker and therapeutic target against cancer. Biochem Pharmacol. 2025 Jan; 231:116646.